DK1345939T3 - Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner - Google Patents

Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner

Info

Publication number
DK1345939T3
DK1345939T3 DK01271374T DK01271374T DK1345939T3 DK 1345939 T3 DK1345939 T3 DK 1345939T3 DK 01271374 T DK01271374 T DK 01271374T DK 01271374 T DK01271374 T DK 01271374T DK 1345939 T3 DK1345939 T3 DK 1345939T3
Authority
DK
Denmark
Prior art keywords
sulfonamide
preparation
substituted imidazotriazinones
imidazotriazinones
substituted
Prior art date
Application number
DK01271374T
Other languages
Danish (da)
English (en)
Inventor
Marc Nowakowski
Reinhold Gehring
Werner Heilmann
Karl-Heinz Wahl
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1345939T3 publication Critical patent/DK1345939T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
DK01271374T 2000-12-18 2001-12-05 Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner DK1345939T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10063108A DE10063108A1 (de) 2000-12-18 2000-12-18 Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen

Publications (1)

Publication Number Publication Date
DK1345939T3 true DK1345939T3 (da) 2006-09-25

Family

ID=7667666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01271374T DK1345939T3 (da) 2000-12-18 2001-12-05 Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner

Country Status (43)

Country Link
US (3) US6777551B2 (xx)
EP (1) EP1345939B1 (xx)
JP (1) JP4441175B2 (xx)
KR (1) KR100787288B1 (xx)
CN (1) CN1227253C (xx)
AR (1) AR032775A1 (xx)
AT (1) ATE328885T1 (xx)
AU (2) AU1708902A (xx)
BG (1) BG66142B1 (xx)
BR (1) BRPI0116227B8 (xx)
CA (1) CA2431933C (xx)
CU (2) CU23341B7 (xx)
CY (1) CY1105197T1 (xx)
CZ (1) CZ297005B6 (xx)
DE (2) DE10063108A1 (xx)
DK (1) DK1345939T3 (xx)
DO (1) DOP2001000295A (xx)
EC (1) ECSP034657A (xx)
EE (1) EE05308B1 (xx)
ES (1) ES2266098T3 (xx)
GT (1) GT200100251A (xx)
HK (1) HK1063799A1 (xx)
HN (1) HN2001000278A (xx)
HR (1) HRP20030583B1 (xx)
HU (1) HU229296B1 (xx)
IL (2) IL156278A0 (xx)
MA (1) MA25927A1 (xx)
MX (1) MXPA03005429A (xx)
MY (1) MY126689A (xx)
NO (1) NO325398B1 (xx)
NZ (1) NZ526477A (xx)
PE (1) PE20020590A1 (xx)
PL (1) PL207294B1 (xx)
PT (1) PT1345939E (xx)
RU (1) RU2299211C2 (xx)
SI (1) SI1345939T1 (xx)
SK (1) SK286894B6 (xx)
SV (1) SV2003000766A (xx)
TW (1) TWI289562B (xx)
UA (1) UA75109C2 (xx)
UY (2) UY27070A1 (xx)
WO (1) WO2002050076A2 (xx)
ZA (1) ZA200304705B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10063108A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE202004006552U1 (de) * 2004-04-26 2004-07-08 Knürr AG Kühlungssystem für Geräte- und Netzwerkschränke
DE102004023069A1 (de) 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US7977478B2 (en) * 2006-03-13 2011-07-12 Dr. Reddy's Laboratories Limited Polymorphic forms of vardenafil
CN101965348B (zh) * 2007-09-06 2013-11-13 上海特化医药科技有限公司 伐地那非的制备方法及其中间体
JP5411161B2 (ja) 2007-12-28 2014-02-12 上海特化医薬科技有限公司 Ｎ−｛１−［３−（２−エトキシ−５−（４−エチルピペラジニル）スルホニルフェニル）−４，５−ジヒドロ−５−オキソ−１，２，４−トリアジン−６−イル］エチル｝ブチルアミド、その調製方法及び用途
WO2011016016A1 (en) 2009-08-07 2011-02-10 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
PL390079A1 (pl) * 2009-12-30 2011-07-04 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób otrzymywania wardenafilu i jego izolacji jako soli z kwasem cytrynowym oraz krystaliczna postać tej soli
CN102134242B (zh) 2011-01-21 2013-08-28 浙江大德药业集团有限公司 一种用于治疗阳痿的快速长效的化合物
CZ2011767A3 (cs) 2011-11-24 2013-06-05 Zentiva, K.S. Zpusob prípravy a izolace solí vardenafilu s kyselinami
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
PL223869B1 (pl) 2013-12-16 2016-11-30 Starogardzkie Zakłady Farm Polpharma Spółka Akcyjna Sposób otrzymywania wardenafilu i jego soli
CN107383020A (zh) * 2017-07-29 2017-11-24 合肥创新医药技术有限公司 一种伐地那非杂质的制备方法
BR112020012239A2 (pt) 2017-12-20 2020-11-24 Klaria Pharma Holding Ab método para preparar um filme mucoadesivo, e, filme mucoadesivo
CN115043757B (zh) * 2022-07-27 2023-08-08 南京桦冠生物技术有限公司 一种连续化制备苄脒盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
DE10063108A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone

Also Published As

Publication number Publication date
US20020137930A1 (en) 2002-09-26
CU20080213A7 (es) 2012-06-21
EE200300294A (et) 2003-10-15
HUP0302467A3 (en) 2004-11-29
CN1481386A (zh) 2004-03-10
NO325398B1 (no) 2008-04-21
UA75109C2 (en) 2006-03-15
TWI289562B (en) 2007-11-11
US6998483B2 (en) 2006-02-14
WO2002050076A3 (de) 2002-08-29
PE20020590A1 (es) 2002-07-13
CZ297005B6 (cs) 2006-08-16
DOP2001000295A (es) 2002-12-15
JP4441175B2 (ja) 2010-03-31
MXPA03005429A (es) 2004-05-04
ES2266098T3 (es) 2007-03-01
BG107892A (bg) 2004-08-31
NO20032731L (no) 2003-06-16
MA25927A1 (fr) 2003-10-01
CA2431933A1 (en) 2002-06-27
ATE328885T1 (de) 2006-06-15
EP1345939B1 (de) 2006-06-07
AR032775A1 (es) 2003-11-26
KR100787288B1 (ko) 2007-12-20
IL156278A0 (en) 2004-01-04
RU2299211C2 (ru) 2007-05-20
SK7502003A3 (en) 2003-10-07
CN1227253C (zh) 2005-11-16
HK1063799A1 (en) 2005-01-14
AU1708902A (en) 2002-07-01
BRPI0116227B8 (pt) 2021-05-25
NZ526477A (en) 2004-12-24
PL365310A1 (en) 2004-12-27
CU23341B7 (es) 2009-02-20
AU2002217089B2 (en) 2006-01-12
JP2004517849A (ja) 2004-06-17
UY37172A (es) 2017-06-30
SI1345939T1 (sl) 2006-10-31
SK286894B6 (sk) 2009-07-06
SV2003000766A (es) 2003-01-13
US20050203298A1 (en) 2005-09-15
PT1345939E (pt) 2006-08-31
DE50110080D1 (de) 2006-07-20
EE05308B1 (et) 2010-06-15
BR0116227B1 (pt) 2014-08-26
HN2001000278A (es) 2002-01-30
CY1105197T1 (el) 2010-03-03
PL207294B1 (pl) 2010-11-30
ZA200304705B (en) 2004-08-12
DE10063108A1 (de) 2002-06-20
BG66142B1 (bg) 2011-07-29
NO20032731D0 (no) 2003-06-16
US20050014756A1 (en) 2005-01-20
IL156278A (en) 2009-06-15
CZ20031692A3 (cs) 2003-10-15
HRP20030583A2 (en) 2005-06-30
CU23873B1 (es) 2013-04-19
ECSP034657A (es) 2003-07-25
CA2431933C (en) 2009-12-01
KR20030063430A (ko) 2003-07-28
HU229296B1 (en) 2013-10-28
BR0116227A (pt) 2003-12-30
HRP20030583B1 (en) 2011-09-30
MY126689A (en) 2006-10-31
HUP0302467A2 (hu) 2003-11-28
GT200100251A (es) 2002-10-01
WO2002050076A2 (de) 2002-06-27
US6777551B2 (en) 2004-08-17
EP1345939A2 (de) 2003-09-24
UY27070A1 (es) 2002-07-31

Similar Documents

Publication Publication Date Title
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1326585T4 (da) Fremgangsmåde til fremstilling af pulverformuleringer
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1309581T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1181272T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1181713T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1272489T3 (da) Fremgangsmåde til præparation af cabergolins krystallinske form I
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1299181T3 (da) Fremgangsmåde til fremstilling af formaldehyd
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1272486T3 (da) Fremgangsmåde til fremstilling af 7-(pyrazol-3-yl)benzoxazoler
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
DK1309607T3 (da) Fremgangsmåde til fremstilling af LHRH-antagonister
DK1392711T3 (da) Fremgangsmåde til fremstilling af xylose